受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
化学式 | C29H32F3N5O3 |
|||
分子量 | 555.59 | CAS No. | 1801787-56-3 | |
Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (179.98 mM) | |
Ethanol | 100 mg/mL (179.98 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | OICR-9429 is a potent antagonist of the interaction of WDR5 with peptide regions of MLL and Histone 3 and reduces viability of acute myeloid leukemia cells in vitro. |
---|---|
in vitro | OICR-9429 binds WDR5 with high affinity (Kd=93±28 nM) and competitively disrupts its interaction with a high-affinity Wdr5-interacting (WIN) peptide of MLL (Kdisp=64±4 nM)[1]. |
in vivo | OICR-9429, a potent WDR5 inhibitor, suppressed proliferation, metastasis and PD-L1-based immune evasion while enhancing apoptosis and chemosensitivity to cisplatin in bladder cancer by blocking the WDR5-MLL complex mediating H3K4me3 in target genes. |
細胞アッセイ | 細胞株 | Primary human AML cells |
---|---|---|
濃度 | 5 μM | |
反応時間 | 72 h | |
実験の流れ | 20,000 viable, actively proliferating primary human AML cells per well were seeded in 96-well plates in triplicates and treated with 0.05% DMSO or OICR-9429. Cell viability was measured using the Cell Titer-Glo luminescent cell viability assay on a VICTOR X4 luminometer after 72 h. |
|
動物実験 | 動物モデル | Male BALB/c nude mice |
投薬量 | 30 or 60 mg/kg | |
投与方法 | i.p. |
|
Data from [Data independently produced by , , Theranostics, 2018, 8(18):5143-5158]
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations [ J Clin Invest, 2023, 133(13)e169993] | PubMed: 37252797 |
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells [ EBioMedicine, 2023, 92:104602] | PubMed: 37148583 |
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5 [ Cell Rep, 2023, 42(9):113145] | PubMed: 37725512 |
MYCN driven oncogenesis involves cooperation with WDR5 to activate canonical MYC targets and G9a to repress differentiation genes [ bioRxiv, 2023, 2023.07.11.548643] | PubMed: 37781575 |
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation [ iScience, 2022, 25(1):103679] | PubMed: 35036869 |
ecDNA hubs drive cooperative intermolecular oncogene expression [ Nature, 2021, 10.1038/s41586-021-04116-8] | PubMed: 34819668 |
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer [ J Exp Clin Cancer Res, 2021, 40(1):203] | PubMed: 34154613 |
Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16INK4a [ Kidney Int, 2019, 96(5):1162-1175] | PubMed: 31570196 |
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity [ Cell Rep, 2019, 26(11):2916-2928.e13] | PubMed: 30865883 |
Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression [Tan Z, et al. Theranostics, 2018, 8(18):5143-5158] | PubMed: 30429891 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。